← FDA Drug Approvals (Drugs@FDA)
BUSULFAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA · Approved 2019-04-18
Drug application
- FDA Application #
ANDA210931- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUSULFAN
- Generic name
- BUSULFAN
- Active ingredients
- BUSULFAN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SHILPA
- Manufacturer
- Armas Pharmaceuticals Inc.
- First approval
- 2019-04-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown